A Boston VC firm is launching a new neuroscience company with a $93M investment that aims to treat disorders including ...

A leading Colorado Alzheimer’s researcher and two senior-level business leaders have been elected to the Alzheimer’s Association of Colorado board of directors. Joining the board on two-year terms are ...

Seaport Therapeutics (“Seaport” or the “Company”), a clinical-stage biopharmaceutical company that is advancing novel neuropsychiatric medicines with a proven strategy and team, today announced the ...

Investing.com -- Deutsche Bank initiated coverage on 11 U.S. biopharma stocks in a note Tuesday, assigning Buy ratings to ...

Founded in 2019, Cybin is operational in Canada, the United States, the United Kingdom, the Netherlands and Ireland. For Company updates and to learn more about Cybin, visit www.cybin.com or follow ...

New research provides evidence that a pattern glare test can be used successfully to detect subclinical autism and schizotypy ...

The exploration of natural products and their structural analogues in neuropsychiatry has historically been a fertile area of research, driven by the ...

Collegium Pharmaceutical, Inc. (Nasdaq: COLL) today announced the appointment of Nancy S. Lurker to its Board of Directors, ...

Canaccord Genuity analysts downgraded Intra-Cellular Therapies (NASDAQ:ITCI) stock from Buy to Hold, adjusting the price target to $132 from the previous $119. The revision follows the recent ...

Medical and technology-focused company HOPE Therapeutics, a subsidiary of NRx Pharmaceuticals, is set to acquire the Kadima Neuropsychiatry Institute, based in La Jolla, California, US.

Industry experts will discuss emerging areas such as gene editing, neuropsychiatry, radiopharmaceuticals, and next-generation weight-loss drugs. Attendees will gain valuable insights into ...

We bring together world-leading researchers to investigate the major causes of mental health problems. We use our clinical, genomic, statistical and bioinformatic expertise to tackle the challenges ...